Klor-con m10 and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Klor-con m10 (potassium chloride), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Vitamin D3, and have Pain.

The phase IV clinical study analyzes which people have Weakness when taking Klor-con m10. It is created by eHealthMe based on reports of 1,290 people who have side effects when taking Klor-con m10 from the FDA, and is updated regularly.

What is Klor-con m10?

Klor-con m10 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,379 Klor-con m10 users. Check the latest studies of Klor-con m10.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,613 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 23, 2026

1,290 people reported to have side effects when taking Klor-con m10.
Among them, 83 people (6.43%) have Weakness.

Among these 83 people:

How long have people been on Klor-con m10 when they have Weakness? *

What is the gender of people who have Weakness when taking Klor-con m10? *

female: 75.68 %
male: 24.32 %

What is the age of people who have Weakness when taking Klor-con m10? *

What are other drugs people take besides Klor-con m10? *

What are other side effects people have besides Weakness? *

Fatigue (feeling of tiredness): 42 people, 50.60%
Headache (pain in head): 22 people, 26.51%
Diarrhea: 21 people, 25.30%
Dizziness: 21 people, 25.30%
Nausea (feeling of having an urge to vomit): 20 people, 24.10%
Muscle Spasms (muscle contraction): 16 people, 19.28%
Joint Pain: 14 people, 16.87%
Tremor (trembling or shaking movements in one or more parts of your body): 14 people, 16.87%
Gait Disturbance: 13 people, 15.66%
Memory Loss: 13 people, 15.66%

What are the existing conditions these people have? *

Pain: 19 people, 22.89%
High Blood Cholesterol: 12 people, 14.46%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 12 people, 14.46%
Multiple Myeloma (cancer of the plasma cells): 9 people, 10.84%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 10.84%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 8.43%
Constipation: 5 people, 6.02%
Cough: 5 people, 6.02%
Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 6.02%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 6.02%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con m10 and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Klor-con m10:

Klor-con m10 (1,379 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Klor-con m10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,613 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con m10) and Klor-con m10 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.